Melphalan and urinary estrogens

Anderson, J.M. and Grant, J.K. and Gettinby, G. (1979) Melphalan and urinary estrogens. British Journal of Cancer, 40 (2). pp. 314-315. ISSN 1532-1827

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

A test of the concept of chemical suppression of ovarian function by cytotoxic drugs previously reported (Anderson et al., 1978, Br. J. Cancer, 37, 477) revealed no supportive evidence from follicular and luteal-phase measurements of plasma oestradiol (E2) in 6 premenopausal women prescribed repeated 5-day courses of melphalan after mastectomy for cancer. To circumvent the difficulties of frequent repeated blood sampling, 3 of these patients were studied in greater depth.

Creators(s):	Anderson, J.M., Grant, J.K. and Gettinby, G.;
Item type:	Article
ID code:	17846
Keywords:	melphalan, urinary estrogens, mastectomy, Probabilities. Mathematical statistics, Neoplasms. Tumors. Oncology (including Cancer), Cancer Research, Oncology
Subjects:	Science > Mathematics > Probabilities. Mathematical statistics Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Department:	Faculty of Science > Mathematics and Statistics Faculty of Engineering > Design, Manufacture and Engineering Management
Depositing user:	Strathprints Administrator
Date deposited:	06 May 2010 13:06
Last modified:	02 Dec 2019 09:39
Related URLs:	Publisher
URI:	https://strathprints.strath.ac.uk/id/eprint/17846
Export data:

CORE (COnnecting REpositories)